Zahra Rezaieyazdi

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Drug development research

Clinical rheumatology

Inflammopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Rezaieyazdi, Sahar Ravanshad, Mandana Khodashahi, Maliheh Bokaeian, Hassan Mehrdad-Majd, Masoumeh Salari
Comparison of the efficacy and safety of methotrexate alone or in combination with leflunomide in the treatment of juvenile idiopathic arthritis: a double-blind, placebo-controlled, randomized trial. Reumatologia 61 (1) (2023)
Zahra Rezaieyazdi, Sahar Ravanshad, Mandana Khodashahi, Maliheh Bokaeian, Hassan Mehrdad-Majd, Masoumeh Salari
Comparison of the efficacy and safety of methotrexate alone or in combination with leflunomide in the treatment of juvenile idiopathic arthritis: a double-blind, placebo-controlled, randomized trial. Reumatologia 61 (1) (2023)
Farhad Shahram, Kamal Esalatmanesh, Alireza Khabbazi, Zahra Rezaieyazdi, Zahra Mirfeizi, Alireza Sadeghi, Mohsen Soroosh, Hoda Kavosi, Majid Alikhani, Shayan Mostafaei
Coronavirus disease 2019 in patients with Behcet's disease: a report of 59 cases in Iran. Clinical rheumatology (2021)
Seyed Shahabeddin Mortazavi-Jahromi, Arman Ahmadzadeh, Zahra Rezaieyazdi, Mona Aslani, Saiedeh Omidian, Abbas Mirshafiey
The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients. Immunopharmacology and immunotoxicology 42 (3) (2020)
Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Saiedeh Omidian, Arman Ahmadzadeh, Zahra Rezaieyazdi, Abbas Mirshafiey
Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug development research 81 (3) (2019)
Zahra Rezaieyazdi, Abid Farooqi, Hossein Soleymani-Salehabadi, Arman Ahmadzadeh, Mona Aslani, Saiedeh Omidian, Arezoo Sadoughi, Zohreh Vahidi, Mandana Khodashahi, Shazia Zamurrad, Seyed Shahabeddin Mortazavi-Jahromi, Hossein Fallahzadeh, Mostafa Hosseini, Zahra Aghazadeh, Parvin Ekhtiari, Hidenori Matsuo, Bernd H A Rehm, Salvatore Cuzzocrea, Antimo D'Aniello, Abbas Mirshafiey
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology 27 (5) (2019)